Leukemias

Forms of leukemia

The most commonly diagnosed types and subtypes of leukemia (as well as some rare forms) are included in this table. Many of the possible treatments are also listed, but be sure to talk with your health care team about all of your treatment options.

 

Cancer type Description Treatment

Acute lymphocytic (lymphoblastic) leukemia (ALL)

• Abnormal lymphoblasts
  develop quickly and block
  the production of normal
  bone marrow cells
• Chemotherapy: asparaginase Erwinia chrysanthemi
  (Erwinaze), clofarabine (Clolar), cyclophosphamide
  (Cytoxan), cytarabine, daunorubicin (Cerubidine),
  doxorubicin (Adriamycin), L-asparaginase (Elspar),
  liposomal vincristine (Marqibo), mercaptopurine
  (Purinethol), methotrexate (Trexall), pegaspargase
  (Oncaspar), prednisone, teniposide (Vumon),
  vincristine (Oncovin)
• Immunotherapy: blinatumomab (Blincyto)
• Radiation therapy
• High-dose chemotherapy and stem cell transplantation
• Targeted therapy: dasatinib (Sprycel), imatinib
  (Gleevec), ponatinib (Iclusig)

Acute precursor B-cell (pre-B-cell) lymphoblastic leukemia

• Fast-growing
• Excess of B-cell
  lymphoblasts
• Chemotherapy: cyclophosphamide (Cytoxan),
  daunorubicin (Cerubidine), doxorubicin (Adriamycin),
  L-asparaginase (Elspar), pegaspargase (Oncaspar),
  vincristine sulfate (Marqibo)
• Immunotherapy: blinatumomab (Blincyto)

Acute T-cell (lymphoblastic) leukemia (T-cell ALL)

• Fast-growing
• Excess of T-cell
  lymphoblasts in bone
  marrow
• Chemotherapy: cyclophosphamide (Cytoxan),
  daunorubicin (Cerubidine), doxorubicin (Adriamycin),
  L-asparaginase (Elspar), nelarabine (Arranon),
  pegaspargase (Oncaspar), prednisone, vincristine
  sulfate (Marqibo)
• High-dose chemotherapy and stem cell transplantation

Burkitt acute lymphoblastic leukemia (B-ALL)

• Rare
• Fast-growing
• Rapid increase of B-cell
  lymphocytes
• Chemotherapy: cyclophosphamide (Cytoxan),
  dexamethasone, doxorubicin (Adriamycin), etoposide
  (Etopophos), methotrexate (Trexall), vincristine sulfate
  (Marqibo)
• High-dose chemotherapy and stem cell transplantation

Ph-positive (Philadelphia-positive) ALL

• Has the gene mutation
  BCR-ABL
• Philadelphia chromosome
  present
• Fast-growing
• Abundance of B-cell
  lymphoblasts
• Chemotherapy: cyclophosphamide (Cytoxan),
  cytarabine, dexamethasone, doxorubicin (Adriamycin),
  methotrexate (Trexall), vincristine sulfate (Marqibo)
• High-dose chemotherapy and stem cell transplantation
• Targeted therapy: dasatinib (Sprycel), imatinib
  (Gleevec), ponatinib (Iclusig)

Acute myeloid leukemia (AML)

• Abnormal myeloblasts
  develop quickly and block
  the production of normal
  bone marrow cells
• Chemotherapy: cyclophosphamide (Cytoxan),
  cytarabine, daunorubicin (Cerubidine), idarubicin
  (Idamycin)
• Growth factors: filgrastim (Neulasta, Neupogen),
  filgrastim-sndz (Zarxio)
• Radiation therapy
• High-dose chemotherapy and stem cell transplantation

Acute promyelocytic leukemia (APL)

• Abnormal promyelocytes
  accumulate in bone
  marrow
• All-trans-retinoic acid (ATRA or Tretinoin), arsenic
  trioxide (Trisenox), idarubicin (Idamycin), hydroxyurea
  (Hydrea)

Adult T-cell leukemia/lymphoma (ATLL)

• 4 subtypes: smoldering,
  chronic, acute,
  lymphomatous
• Chemotherapy: cyclophosphamide (Cytoxan),
  doxorubicin (Adriamycin), prednisone, vincristine
  sulfate (Marqibo)
• Immunotherapy: interferon alfa

Chronic lymphocytic leukemia (CLL)

• Slow-growing
• Excess of abnormal B- or
  T-cell lymphocytes
• Watchful waiting
• Chemotherapy: bendamustine (Treanda),
  chlorambucil, cyclophosphamide (Cytoxan),
  doxorubicin (Adriamycin), fludarabine,
  mechlorethamine (Mustargen), prednisone
• Growth factors: filgrastim (Neulasta, Neupogen)
• Immunotherapy: alemtuzumab (Campath),
  obinutuzumab (Gazyva), ofatumumab (Arzerra),
  rituximab (Rituxan)
• Radiation therapy
• High-dose chemotherapy and stem cell transplantation
• Targeted therapy: ibrutinib (Imbruvica), idelalisib
  (Zydelig), venetoclax (Venclexta)

B-cell chronic lymphocytic leukemia (B-CLL)

• Rapid increase of
  abnormal B-cell
  lymphocytes
• Chemotherapy: bendamustine (Treanda),
  cyclophosphamide (Cytoxan), fludarabine
• Immunotherapy: alemtuzumab (Campath), rituximab
  (Rituxan)
• High-dose chemotherapy and stem cell transplantation
• Targeted therapy: ibrutinib (imbruvica), idelalisib
  (Zydelig)

Chronic myeloid leukemia (CML)

• Grows slowly at first
• Affects myeloid cells
• Philadelphia chromosome
  usually present
• Chemotherapy: busulfan (Busulfex),
  cyclophosphamide (Cytoxan), cytarabine, hydroxyurea
  (Hydrea), mechlorethamine (Mustargen), omacetaxine
  (Synribo)
• Immunotherapy: interferon alfa
• High-dose chemotherapy and stem cell transplantation
  (only for advanced phases of disease)
• Targeted therapy: bosutinib (Bosulif), dasatinib
  (Sprycel), imatinib (Gleevec), nilotinib (Tasigna),
  ponatinib (Iclusig)

Chronic myelomonocytic leukemia (CMML)

• Elevated number of
  monocytes
• Affects primarily people
  ages 65-75
• Chemotherapy: azacitidine (Vidaza), cytarabine,
  decitabine (Dacogen), hydroxyurea (Hydrea)
• High-dose chemotherapy and stem cell transplantation

Hairy cell leukemia (HCL)

• Rare and slow-growing
• Cells appear hairy under
  microscope
• More common in men
• Average age at diagnosis,
  50
• Watchful waiting
• Chemotherapy: chlorambucil, cladribine (Leustatin),
  pentostatin (Nipent), prednisone
• Immunotherapy: interferon alfa, rituximab (Rituxan)

Large granular lymphocytic leukemia (LGLL)

• Affects T-cells or NK cells
• Larger lymphocytes with
  noticeable granules
• Chemotherapy: cyclophosphamide (Cytoxan),
  doxorubicin (Adriamycin), methotrexate (Trexall),
  prednisone, cyclosporine
• Growth factors: filgrastim (Neulasta, Neupogen)

Natural killer cell leukemia (NK)

• Rare
• Aggressive growth of NK
  cells
• Chemotherapy: cyclophosphamide (Cytoxan),
  daunorubicin (Cerubidine), dexamethasone,
  doxorubicin (Adriamycin), L-asparaginase (Elspar),
  methotrexate (Trexall), prednisone
• High-dose chemotherapy and stem cell transplantation

Prolymphocytic leukemia (PLL)

• Rare
• Affects B- or T-cell
  lymphocytes
• Numerous immature
  lymphocytes
• Affects primarily people
  ages 65-70
• Chemotherapy: chlorambucil, cyclophosphamide
  (Cytoxan), doxorubicin (Adriamycin), fludarabine,
  pentostatin (Nipent), vincristine (Oncovin)
• Immunotherapy: alemtuzumab (Campath)
• High-dose chemotherapy and stem cell transplantation

 

Previous Next

 



Register Now! Sign Up For Our Free E-Newletter!

Read Inspiring Cancer Survivor Stories

Order Your Guides Here